Jean Pierre Maffrand

707 total citations
7 papers, 597 citations indexed

About

Jean Pierre Maffrand is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Social Psychology. According to data from OpenAlex, Jean Pierre Maffrand has authored 7 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Cellular and Molecular Neuroscience and 2 papers in Social Psychology. Recurrent topics in Jean Pierre Maffrand's work include Neuroendocrine regulation and behavior (2 papers), Electrolyte and hormonal disorders (2 papers) and Receptor Mechanisms and Signaling (2 papers). Jean Pierre Maffrand is often cited by papers focused on Neuroendocrine regulation and behavior (2 papers), Electrolyte and hormonal disorders (2 papers) and Receptor Mechanisms and Signaling (2 papers). Jean Pierre Maffrand collaborates with scholars based in France. Jean Pierre Maffrand's co-authors include Gérard Le Fur, Florence Oury-Donat, Philippe Soubrié, Natalio Vita, André Bachy, Jean Marc Herbert, F. Lacheretz, Mohammed Bensaïd, Pietro Marini and M. Arnone and has published in prestigious journals such as Hepatology, Kidney International and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Jean Pierre Maffrand

7 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean Pierre Maffrand France 6 304 278 178 148 110 7 597
Donald V. Daniels United States 12 315 1.0× 497 1.8× 48 0.3× 142 1.0× 23 0.2× 19 764
S. Heisler Canada 16 222 0.7× 380 1.4× 26 0.1× 150 1.0× 76 0.7× 42 756
Mohammed Bensaïd France 7 107 0.4× 181 0.7× 274 1.5× 189 1.3× 119 1.1× 11 569
Naomi Murai Japan 6 218 0.7× 305 1.1× 247 1.4× 35 0.2× 14 0.1× 11 761
Richard P. Burt United Kingdom 11 199 0.7× 322 1.2× 40 0.2× 157 1.1× 24 0.2× 13 569
Jean-Claude Camus Belgium 15 505 1.7× 446 1.6× 24 0.1× 172 1.2× 24 0.2× 25 724
Colette N. Thaw United States 13 334 1.1× 397 1.4× 17 0.1× 273 1.8× 39 0.4× 20 750
C. Ventra Italy 11 233 0.8× 261 0.9× 25 0.1× 56 0.4× 26 0.2× 29 457
Suleiman Al‐Sabah Kuwait 14 388 1.3× 515 1.9× 39 0.2× 256 1.7× 48 0.4× 31 783
Wesley Lebel United States 8 672 2.2× 627 2.3× 50 0.3× 98 0.7× 14 0.1× 12 992

Countries citing papers authored by Jean Pierre Maffrand

Since Specialization
Citations

This map shows the geographic impact of Jean Pierre Maffrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Pierre Maffrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Pierre Maffrand more than expected).

Fields of papers citing papers by Jean Pierre Maffrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Pierre Maffrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Pierre Maffrand. The network helps show where Jean Pierre Maffrand may publish in the future.

Co-authorship network of co-authors of Jean Pierre Maffrand

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Pierre Maffrand. A scholar is included among the top collaborators of Jean Pierre Maffrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Pierre Maffrand. Jean Pierre Maffrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Gary‐Bobo, Magali, Philip Janiak, Pietro Marini, et al.. (2007). Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats. Hepatology. 46(1). 122–129. 243 indexed citations
2.
Grélot, Laurent, et al.. (2001). A nonpeptide vasopressin V1a receptor antagonist, SR 49059, does not prevent cisplatin‐induced emesis in piglets. Fundamental and Clinical Pharmacology. 15(3). 189–200. 3 indexed citations
3.
Gal, Claudine Serradeil‐Le, Danielle Raufaste, Gilles Guillon, et al.. (2000). Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [3H]-SR 121463. Kidney International. 58(4). 1613–1622. 21 indexed citations
4.
Vita, Natalio, Florence Oury-Donat, Pascale Chalon, et al.. (1998). Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells. European Journal of Pharmacology. 360(2-3). 265–272. 112 indexed citations
5.
Gully, Danielle, Bernard Labeeuw, Robert Boigegrain, et al.. (1997). Biochemical and Pharmacological Activities of SR 142948A, a New Potent Neurotensin Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 280(2). 802–812. 181 indexed citations
6.
Herbert, Jean Marc, et al.. (1992). Effect of SR 27417 on oedema formation induced in rabbit skin by platelet-activating factor or antigen. European Journal of Pharmacology. 216(2). 175–181. 7 indexed citations
7.
Maffrand, Jean Pierre, et al.. (1991). Protective effect of SR 27417, a novel PAF antagonist, on lethal anaphylactic and endotoxin-induced shock in mice. European Journal of Pharmacology. 205(3). 271–276. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026